KOSUNI CRYPTO
Korea's Crypto Pulse, in English
$BTC $ETH $XRP $SOL $DOGE
News
Bearish

Genome Editing Stocks Drop 5-11% After Anthropic's CRISPR-like Enzyme Discovery

Published September 24, 2026 11:55 AM · 4 views $CRSP $BEAM $PRME
Genome Editing Stocks Drop 5-11% After Anthropic's CRISPR-like Enzyme Discovery

Following Anthropic's announcement that its AI model Claude identified a new enzyme system with repetitive DNA sequences similar to CRISPR, genome editing-related stocks dropped 5-11% on March 23 (local time). CRISPR Therapeutics ($CRSP) fell 5.54%, Beam Therapeutics ($BEAM) declined 6.02%, and Prime Medicine ($PRME) dropped 11.58%.

Anthropic officially announced on March 23 that Claude searched through large-scale DNA sequences using approximately 950 AI agents and 21 million tokens over about 21 hours. The model discovered repetitive DNA sequences and associated genes near reverse transcriptase genes, which Anthropic named the Array-Associated Reverse Transcriptase (ART) system. Anthropic noted that ART is primarily found in bacteriophages and creates multiple short RNAs from repeated sequences, though its main function remains unknown and it has not been proven to edit DNA like mature gene editing tools.

Korean Source

This article is an English localization of a Korean-language crypto news report. Original headline: 23일 유전자 편집주 5~11% 하락…앤트로픽, CRISPR 유사 반복 배열 효소 발표